Recombinant Activated Factor VII (rFVIIa) in the Management of Major Obstetric Haemorrhage: A Case Series and a Proposed Guideline for Use

Major obstetric haemorrhage remains a significant cause of maternal morbidity and mortality. Previous case reports suggest the potential benefit of recombinant activated factor VII (rFVIIa: NovoSeven(R)) as a haemostatic agent. We performed a retrospective review of the use of rVIIa in major obstetr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bomken, Charlotte, Mathai, Sue, Biss, Tina, Loughney, Andrew, Hanley, John
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2009
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817503/
https://www.ncbi.nlm.nih.gov/pubmed/20148069
http://dx.doi.org/10.1155/2009/364843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817503/
https://www.ncbi.nlm.nih.gov/pubmed/20148069
http://dx.doi.org/10.1155/2009/364843

Ejemplares similares